Roman J, Yuan Y, Xu Y, Zhu Q, et al. A functional and mechanistic explanation for the unique clinical success of the glucokinase activator dorzagliatin for treatment of type 2 diabetes. Diabetes 2025 Apr 24:db250066. doi: 10.2337/db25-0066.
PMID: 40272935